ESGCT 2022: The New Normal for the Gene Therapy Community

Hum Gene Ther. 2022 Sep;33(17-18):841. doi: 10.1089/hum.2022.29217.editorial.

Author

Terence R Flotte¹

Affiliation

¹ Editor-in-Chief, Human Gene Therapy, Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, New York, USA.

PMID: 36125440
DOI: 10.1089/hum.2022.29217.editorial

No abstract available

Publication types

Editorial

MeSH terms

Community Health Services*
Genetic Therapy*
Humans